These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36943123)

  • 1. [Revolution in the field of primary and secondary hyperoxalurias: Stay tuned!].
    Bacchetta J; Cochat P
    Med Sci (Paris); 2023 Mar; 39(3):262-264. PubMed ID: 36943123
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria.
    Hoppe B; Leumann E; von Unruh G; Laube N; Hesse A
    Front Biosci; 2003 Sep; 8():e437-43. PubMed ID: 12957811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical and genetic diagnosis of the primary hyperoxalurias: a review.
    Rumsby G
    Mol Urol; 2000; 4(4):349-54. PubMed ID: 11156702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary hyperoxaluria].
    Cochat P; Fargue S; Bacchetta J; Bertholet-Thomas A; Sabot JF; Harambat J
    Nephrol Ther; 2011 Jul; 7(4):249-59. PubMed ID: 21636340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on primary hyperoxaluria.
    Hoppe B
    Nat Rev Nephrol; 2012 Jun; 8(8):467-75. PubMed ID: 22688746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives in the assessment and management of patients with primary hyperoxaluria type I.
    Morgan SH; Watts RW
    Adv Nephrol Necker Hosp; 1989; 18():95-106. PubMed ID: 2493726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma.
    Moinuddin I; Bala A; Ali B; Khan H; Bracamonte E; Sussman A
    Hum Pathol; 2016 Feb; 48():163-6. PubMed ID: 26614399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the role of genotyping in the diagnosis of the primary hyperoxalurias.
    Rumsby G
    Urol Res; 2005 Nov; 33(5):318-20. PubMed ID: 16208537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An unexpected cause of progressive renal failure in a 66-year-old male after liver transplantation: secondary hyperoxaluria.
    Beloncle F; Sayegh J; Duveau A; Besson V; Croue A; Subra JF; Augusto JF
    Int Urol Nephrol; 2013 Aug; 45(4):1209-13. PubMed ID: 22395848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folding Defects Leading to Primary Hyperoxaluria.
    Oppici E; Dindo M; Conter C; Borri Voltattorni C; Cellini B
    Handb Exp Pharmacol; 2018; 245():313-343. PubMed ID: 29071511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias.
    Rumsby G; Williams E; Coulter-Mackie M
    Kidney Int; 2004 Sep; 66(3):959-63. PubMed ID: 15327387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperoxaluria: Comprehensive mutation screening of the disease causing genes and spectrum of disease-associated pathogenic variants.
    Abid A; Raza A; Khan AR; Firasat S; Shahid S; Hashmi S; Zafar MN; Sultan S; Khaliq S; Rizvi SA
    Clin Genet; 2023 Jan; 103(1):53-66. PubMed ID: 36185032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferent RNA treatment: Example of primary hyperoxaluria].
    Cochat P; Sellier-Leclerc AL; Bertholet-Thomas A; Bacchetta J
    Nephrol Ther; 2021 Apr; 17S():S23-S26. PubMed ID: 33910694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperoxaluria and urolithiasis in young children: an atypical presentation.
    Monico CG; Milliner DS
    J Endourol; 1999 Nov; 13(9):633-6. PubMed ID: 10608514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical approach to diagnosis and differentiation of primary hyperoxalurias: an update.
    Petrarulo M; Vitale C; Facchini P; Marangella M
    J Nephrol; 1998; 11 Suppl 1():23-8. PubMed ID: 9604805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of renal failure in the primary hyperoxalurias.
    Watts RW
    Nephron; 1990; 56(1):1-5. PubMed ID: 2234239
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperoxaluria and systemic oxalosis: current therapy and future directions.
    Bobrowski AE; Langman CB
    Expert Opin Pharmacother; 2006 Oct; 7(14):1887-96. PubMed ID: 17020415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary hyperoxalurias: diagnosis and treatment.
    Ben-Shalom E; Frishberg Y
    Pediatr Nephrol; 2015 Oct; 30(10):1781-91. PubMed ID: 25519509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the identification and management of inherited hyperoxalurias.
    Sas DJ; Harris PC; Milliner DS
    Urolithiasis; 2019 Feb; 47(1):79-89. PubMed ID: 30535828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.